BioCentury
ARTICLE | Company News

Medtronic, Wyeth, Yamanouchi Pharmaceutical Co. sales and marketing update

February 10, 2003 8:00 AM UTC

MDT's Medtronic Sofamor Danek subsidiary will exclusively market in Europe WYE's and Yamanouchi's rhBMP-2/ACS recombinant protein bone graft substitute. The protein is marketed as InductOs to treat ...